Breaking News
Sort by:
Top Post
Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and […]
Redbud Raises $10M in Series A Round as CRO Focusing on Science-driven Clinical Development
Redbud Medicine, the Delaware-headquartered contract research organization (CRO) announced on Monday following the completion of a series […]
Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations
Deka Biosciences (“Deka”), a biotech company focused on the development of novel cytokine therapies to […]
WHO Grants Prequalification to GSK’s Mosquirix – the First and Only Approved Malaria Vaccine
GSK plc (LSE/NYSE: GSK) announced today that the World Health Organization (WHO) has awarded prequalification […]
PhoreMost Enters Multi-project Drug Target Discovery Collaboration With Roche
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced […]
Ensysce Biosciences and Quotient Sciences Announce a Partnership on the Development and Clinical Testing of Ensysce's PF614-MPAR, a Novel Opioid Designed to Prevent Abuse and Overdose
Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC) (OTC PINK: ENSCW), a clinical-stage biotech company […]
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the […]
Swissmedic Authorizes Moderna’s Omicron-targeting Bivalent Booster Candidate, mRNA-1273.214
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Single Pill Proves More Effective at Preventing Further Heart Attack or Stroke
A single pill containing medication to lower cholesterol and blood pressure and stop clotting is […]
Bio-Rad Introduces Anti-Evolocumab Antibodies for Use in Preclinical and Clinical Drug Development
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]
GNS and Servier Announce AI Collaboration to Advance Multiple Myeloma Drug Discovery and Clinical Development
GNS, the leader in the use of “Digital Twins” and Causal AI & biosimulation technology […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more